Convergent syntksis of cyclic branckd tetraribonucleotide 9, modelling tk lariat of pre-mRNA processing reaction (Splicing), is reported. Tkfirst key step in tk present strategy involves tk condensation of tk appropriately protected 5 '-O-levtdinyl-G3 35 U3 'phosphodiester block 4 wirh tk 3 *,S 'dihydro&-N-bemoyl-2 '-Opixyl(9-pknylxantkn-9-yl)adenosine 5 , in presence of an activating agent, to give 40 (53%). Ckmospecijic phosphoiylation of 3'-OH of 6a qBordcd tk intermediate 0 (88%) which was treated with mild acid to achieve a regiospecific removal of tk 2'-O-p@1 group to give conqwnnd 6c (99%). Tk second key step involved tk introduction of biscyanoethylpkxphotriester moiety w the 2'-OH of tk branch-point adenosine in 6c. in one single
In the last few years we have been engaged in trying to understand the structural significance of heptamerls. During these conformational studies*hF~i-s it became clear to us that the open-chained branch-RNA may only partly mimic and model the naturally-occurring lariat RNA formed in the Splicing reaction. This is primarily due to the fact that the conformational stress and strain inbuilt in the naturally-occurring lariat RNA owing to its cyclic nature is not reproduced in the synthetic open-chained branched RNA. Clearly, the true mimic and the model of the naturally-occuning lariat RNA is the synthetic cyclic counterpart in which the 3'-hydroxy of 2-W linked guanosine is cyclized to the S-hydroxyl group through a phosphodiester linkage.
Next step would be to observe how and when the conformational stress and strain of the lariat RNA is released as the ring size of the lariat becomes larger! NMR spectroscopic studies on such cyclic lariat RNA and their
analogues will reveal what effect the presence of the loop may have on its constituent sugar residues, the phosphate backbone and the base conformations, and how will this effect change upon enlarging the ring size! These are the rationals and questions that have directed our attention towards the synthesis of branched cyclic RNA. As a starting point, we have therefore chosen to regiospecifically synthesize the branched cyclic RNA which have all conserved nucleobases and constitute the smallest possible RNA lariat mimicing the naturally-
All the synthetic strategies reported so far for the assembly of cyclic oligo(deoxy)ribonucleotides am based upon the phosphotriester approach, except for an early work by Khorana et al 2, who isolated cyclic oligomers and especially cyclic dithymidylic acid as by-products in the course of their work on synthesis of oligothymidylic acids using the phosphodiester approach. The intramolecular cyclization reactions in these reports are effected by condensing agents (ArSO2X type) under high dilution conditions, except for a recent work by Bonora er al 3 for the preparation of a number of cyclic oligodeoxyadenylic acids in which the cyclization was effected by 2-chlorophenyl-bis-O,O-( I-benzotriazolyl)phosphate. Hsu et al 4 described the synthesis of three cyclic diribonucleosidediphosphates r(ATp), r(ATp) and r(u?p). van Boom et al synthesized r(GpGp) -5 and later his group prepared two cyclic tetra-RNAs, two cyclic hexa-DNAs and two cyclic octa-DNA&. A solid phase synthesis was developed by Barbato et al 7~ which produced up to heptacyclic-oligodeoxycytidylic acids. More recently Reese et al 9 described the synthesis of cyclic oligothymidylic acids together with a cyclic hexa-DNA of a mixed sequence. ( WPGO.)' Following point@ may be noted regarding the present synthesis of lariat RNA, p(s)U(33p(~?+,.)~C (9): (i) The levulinyl (Lev) protecting group on the S-hydroxyl function in all the intermediates up to 7a was found to be compatible with the test of the protecting groups necessary for this strategy, and it can be selectively removed over the cyanoethyl group of the 2'-biscyanoethylphosphotriester moiety at the branchpoint in 7a. The intramolecular cyclization of 7c was then brought about by addition of 9 equivalents of MSNT to a 4 mM pyridine solution of 7c, after over night stirring at room tempemture, to give the fully protected cyclic branced tetramer 8 in 61% yield [#tP-NMR, Panel (e) in Fig. 11 . Compound 8 was then &protected in the usual manner and the product was isolated from the product mixture by DEAE-Scphadex column chromatography followed by semi-preparative RP-HPLC (Fig. 2) and Dowex ion-exchange column chromatography to finally give pure Na+ salt cyclic branched tenamer 9 (see experimental section for details) in 30% yield (432 Am o.d units) which has been subsequently spectroscopically characterized (vide in@). conformations. We have subsequently performed a two dimensional 1 H, 31P-correlation experiment in order to establish unequivocally the presence of a covalently linked phosphodiester group connecting the S-terminal uridine (A5'+3'U) and 3'-terminal guanosine (A5'+2%) residues in the lariat RNA 9. Fig 3D shows the ID 3*P-NMR spectra, and Fig. 6 show the proton detected inverse 1 H ,3lP-correlation experiment in the absolute mode at 298K in RO solution (-6 mM). Note that the connectivities of all four phosphates to the respective 2' or 3' proton of the fust sugar residue to the S/5" of the second sugar have indeed been found in the JH. 3*Pcorrelation experiment (Fig. 6 ). For example, the phosphate resonance at 6 -1.532 is found to have J-couplings with 5'/5"U, 4'U, 3'G and 2'G suggesting that it can be unequivocally assigned to G3'pSU in the target compound 9. Clearly such JH, 31P couplings are only possible if the U and G residues are covalently linked through a phosphodiester residue between 3'G to 5'/5"U confirming the cyclic nature of the target molecule 9.
The long-range couplings of 3'+5'-phosphate to 4'U and 2'G in G3'pSU moiety are clearly due to coupling Further work is now in progress to synthesize cyclic branched oligomers with an increased number of nucleotide units both in the 2'-+5'-loop of the branch-point A and in its 3'-"tail" . c. suhm er al. EXPERIMENTAL rH-NMR spectra were recorded in 6 scale with Jeol FX 90 Q and Bruker AMXdOO spectrometers at 90 and 500 MHz respectively, using TM8 or H@ (set at 4.7 ppm) as intemaJ standards. 3*P-NMR spectra were recorded at 36 and 202 MHz in the same solvent using 85 % phosphoric acid or CAMP as external standard. TLC was carried out using pm-coated silica gel FW plates in the following dichloromethane-methanol mixtures: 1.30 (s, 9H) r-butyZPhCO-; 1.25 (t. 9H) CH3 of triethylammonium; 3*P-NMR (CDCl3+CD3OD): -7.91, -8.13 ppm. Compound 6a The 3'-phosphodiester block 4 (1.57 g, 0.95 mmol) was condensed with 6-N-benzoyl-2'-0-pixyladenosinetu5 (555 mg, 0.89 mmol) in dry pyridine (8 ml) by addition of distilled N-methylimidazole (379 ~1, 4.76 mmol) followed by addition of I-mesitylenesulfonyl chloride (519 mg, 2.38 mmol). The reaction mixture was then stirred for 50 min at room temperature. Aqueous ammonium bicarbonate work up followed by silica gel column chromatography (using the silica gel pm-washed with 1% Et3N -CH2C12 mixture followed by washing with pure CHzC12) with O-396 ethanol/O.5% pyridine in CH2C12 afforded 6a as a white powder after co-evaporation with toluene and cyclohexane (l.OIg. 53%). Rt: 0.59 (C); tH-NMR (CDClg+lutidine): 9.18 (br, 1H) NH; 8.68, 8.60, 8.56 (4.67 ml, 0.93 mmol) for 60 min. Aqueous ammonium bicarbonate work up followed by silica gel column chromatography (using the silica gel pm-washed with 1% EgN -CH$lz mixture followed by washing with pure CH$l$ with O-796 EtGH/l% pyridine in CH$!l2 afforded 6b as a white powder after co-evaporation with toluene and cyclohexane (1.0 g, 88%). Rt : -7.47, -7.66, -7.81, -7.96.8.06 ppm. Compound 6c : The 3'-phosphodiester block 6b (1.0 g. 0.41 mmol) was dissolved in 2% EtGH-CH$I2 and chilled to 0 Oc in an ice bath. Trichlotoacetic acid (TCA) (668 mg, 4.1 mmol) was dissolved in the second half of the 2% EtOHCH2C12 solution and chilled to 0 eC prior to addition into the above solution of 6b. The final concentration of TCA was 0.055 M. After stirrlng for 20 mitt, the solution was pouted into 0.2M ammonium bicarbonate solution which was saturated with ammonium chloride and acidified with dry ice and this aqueous phase @H -6.5) was extracted with dichloromethane (3 x 50 ml). The organic phase was dried in magnesium sulfate and filtered and evapotated. The residue was dissolved in a small amount of dichlommethane and pipetted into a diethylether-hexane solution (150 ml) (2:l v/v). The precipitate was centrifuged, the supematant was decanted and the white pixyl-free solid was dried in vucuo (891 mg, quantitative (1.0 g, 4.07 mmol) was weighed into a dry 100 ml round bottomed flask and dry 15% dimethylformarni& / acetonitrile solution (14 ml) was added under argon (argon balloon). Then dry and sublimed tetraxole (855 mg, 12.2 mmol) was added under stirring, and it rapidly went into solution followed by a quick formation of a precipitate. After 3 min stirring, solid 2'-hydroxy-3'-phosphodiester block 6e (891 mg, 0.41 mmol) was added to the colorless suspension and the clear reaction solution was then stirred for 40 min at room temperature under argon. A solution of O.lM 12 / tetrahydtofuran / pyridine / Hz0 (7:2:1 v/v/v) (43 ml) was added and the reaction solution was stirred for 15 min, poured into O.lM sodium thiosulfate / concentrated ammonium bicarbonate solution and extracted three times with dichloromethsne. The pyridine-free gum obtained after toluene co-evaporation of the organic residue was then purified by short silica gel column chromatography (2-9% EtGH in CHzC12) to finally give the 3'-phosphodiester-2'-biscyanoethoxyphosphotriester block 6d as a white powder after co-evaporation with toluene and cyclohexane (659 mg, 68%). Rf 2.40 (s, 3H) -COPhCH3; 2.07 (s, 3H) CH#ZOCH$H2CO-; 1.46 (m, 12H) tetrahydropyranyl-;
1.29 (s. 9H) r-butylPhCG-; 1.25 (t, 9H) CH3 of triethylammonium; 31P-NMR (CDC13+CD3OD) : -4.66, -7.66, -7.84, 8.06, -8.15 ppm. Compound 7a. A mixture of 6d (659 mg, 0.274 mmol) and 2',3'-di-0-acetyl-4-N-benxoylcytidine (180 mg, 0.417 mmol) was co-evaporated with dry pyridine and redissolved in dry pyridine (2 ml). l-mesitylenesulfonyl-3-nitro-1,2.4-ttiazole (MSNT) (495 mg, 1.67 mmol) was added and the reaction mixture was stirred for 6 h at room temperature. Aqueous ammonium bicarbonate work up followed by silica gel column chromatography (2-5% EtGH in CH&!l~) gave the fully protected oligomer 7a as a white powder after co-evaporation with toluene and cyclohexane (560 mg, 75%); Rf: 0.51 (D); lH-NMR (CDCl3): 9.11 (br, 1H) NH; 8. 75,8.74, 8. 2.06 (s. 6H) 2 x -CGCH3; 1.43 ?m, 212H) tetrahydropyranyl-; 1.29 (s, 9H) r-bu@PhCO-; 3lP-NMR (CDC13) : -3.07, -3.37, -6.61. 7.32, -7.42, -7.59, -7.81, -7 .91 ppm. Compound 7b. 7a (268 mg, 0.1 mmol) was dissolved in dry pyridine (1 ml). Then 0.5 M hydraxine hydrate (1 mmol) in pyridine/acetic acid (3:2 v/v) (1 ml) was added, and after 5 mitt stitrlng at room temperature the reaction was quenched by addition of pentane-2,4dione (103 pl. 1 mmol). The reaction mixture was then poured into concentrated ammonium bicarbonate solution and extracted with dichloromethane (3 x 50 ml). 'Ihe pyridinefree gum obtained after evaporation and co-evaporation with toluene was purified by silica gel chromatography (3-5%EtGH in CH$!12) to give 7b as a white powder after co-evaporation with toluene and cyclohexane (216 mg, 83%); Rf: 0.50 (C); IH-NMR (CDC13): 9.24 (br, 1H) NH; 8.75, 8.73 (2 x s, 1H)  
